ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,113Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1802

$1.04M Total Retail Price of All Prescriptions

Rank: 5 out of 1802

536 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 536 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 536 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,103 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LISINOPRIL 407 310 1 3
PRAVASTATIN SODIUM 401 291 2 19
AMLODIPINE BESYLATE 387 279 3 6
METFORMIN HCL 362 261 4 11
OMEPRAZOLE 354 211 5 4
HYDROCODONE-ACETAMINOPHEN 342 175 S3 6 10
LEVOTHYROXINE SODIUM 320 271 7 2
MELOXICAM 292 188 8 59
FUROSEMIDE 254 183 9 5
TRIAMTERENE-HCTZ 207 154 10 49
SERTRALINE HCL 202 117 11 20
SIMVASTATIN 201 145 12 1
ZOLPIDEM TARTRATE 200 115 13 27
POTASSIUM CHLORIDE 187 147 14 15
GABAPENTIN 175 107 15 16
WARFARIN SODIUM 172 124 16 7
GLIPIZIDE 147 102 17 51
LOSARTAN POTASSIUM 147 80 17 18
HYDROCHLOROTHIAZIDE 140 91 19 8
ONGLYZA 139 78 20 167
CARVEDILOL 139 112 20 36
TAMSULOSIN HCL 136 113 22 28
METOPROLOL TARTRATE 128 107 23 9
TRICOR 125 98 24 137
TRAMADOL HCL 119 72 25 22
ATORVASTATIN CALCIUM 113 85 26 14
LOVAZA 100 51 27 138
ATENOLOL 99 85 28 12
CYCLOBENZAPRINE HCL 93 31 R 29 69
CLOPIDOGREL 92 78 30 48
PLAVIX 90 72 31 81
RANITIDINE HCL 86 79 32 30
NAMENDA 85 79 33 34
ALLOPURINOL 84 59 34 24
LANTUS 84 46 34 47
ACETAMINOPHEN-CODEINE 83 38 S3 36 85
MUPIROCIN 81 43 37 251
DONEPEZIL HCL 79 66 38 26
ALENDRONATE SODIUM 78 75 39 21
LYRICA 78 61 39 107
SUCRALFATE 76 51 41 192
ADVAIR DISKUS 72 44 42 32
PANTOPRAZOLE SODIUM 72 33 42 44
METOPROLOL SUCCINATE 70 60 44 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 36 45 135
NAPROXEN 68 43 46 94
PROAIR HFA 68 22 46 58
SINGULAIR 68 52 46 131
CILOSTAZOL 61 38 49 324
INSULIN SYRINGE 57 38 50 157
NEXIUM 57 31 50 50
FENOFIBRATE 55 44 52 56
GEMFIBROZIL 53 37 53 83
HUMALOG 53 28 53 129
PHENYTOIN SODIUM EXTENDED 53 17 53 154
PEN NEEDLE 52 32 56 124
FLOVENT HFA 52 27 56 198
ENALAPRIL MALEATE 52 27 56 40
ZETIA 51 43 59 79
OXYBUTYNIN CHLORIDE 50 38 60 87
DIGOXIN 50 50 60 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.